Atika Capital Management’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-280
Closed -$7.79M 112
2022
Q3
$7.79M Buy
+280
New +$71.2K 0.66% 58
2022
Q2
Sell
-900
Closed -$18.7M 100
2022
Q1
$18.7M Buy
+900
New +$148K 1.57% 29
2020
Q4
Sell
-36,000
Closed -$2.73M 151
2020
Q3
$2.73M Buy
+36,000
New +$2.04M 0.22% 93

Other funds holding SWAV

Atika Capital Management's SWAV Position: Q2 2024 in Review

Atika Capital Management sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 114,500 shares — an estimated $37.3M sold.

Atika Capital Management first reported a position in SWAV in Q4 2019 and held it in 16 quarters. The position peaked at $59.6M in Q1 2022. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Atika Capital Management reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Atika Capital Management sold 114,500 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $37.3M.
  • Atika Capital Management first reported a position in Shockwave Medical, Inc. Common Stock in Q4 2019 and held it in 16 quarters.
  • Atika Capital Management's Shockwave Medical, Inc. Common Stock position peaked at $59.6M in Q1 2022.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Atika Capital Management's 13F filing for Q2 2024, filed 13 Aug 2024.